Skip to main content

Table 4 Adjusted and unadjusted total and analytical OSCE results

From: Assessment of an intensive education program for pharmacists on treatment of tobacco use disorder using an objective structured clinical examination: a randomized controlled trial

 

Smoking training group

Contraception training group

Unadjusted mean difference

Adjusted a mean difference

Mean

Standard Deviation

Mean

Standard Deviation

Mean

Standard Error

p-value

R2

Mean

Standard Error

p-value

R2—adjusted

Case 1: ‘Healthy’ adult smoker

  Total Analytical Score (# of items:26)

12.1

3.0

6.4

2.4

5.7

0.6

 < 0.001*

49.7%

6.3

0.60

 < 0.001*

63.3%

  Final Score

15.2

4.0

8.8

3.1

6.4

0.8

 < 0.001*

41.8%

7.2

0.80

 < 0.00*

59.2%

Case 2: Pregnant smoker

  Total Analytical Score (# of items:24)

11.8

3.8

3.8

2.2

8.0

0.7

 < 0.001*

58.9%

8.4

0.84

 < 0.001*

59.7%

  Final Score

15.3

4.5

6.2

3.0

9.1

0.9

 < 0.001*

55.3%

9.6

1.01

 < 0.001*

58.1%

Case 3: Smoking teenager

  Total Analytical Score (# of items:20)

10.7

3.4

4.7

2.3

6.0

0.7

 < 0.001*

48.7%

6.3

0.75

 < 0.001*

50.7%

  Final Score

14.2

4.3

7.7

3.4

6.5

0.9

 < 0.001*

39.1%

7.1

0.98

 < 0.001*

43.0%

Case 4: Relapse prevention in a patient who recently quit smoking and has withdrawal symptoms

  Total Analytical Score (# of items:26)

11.2

3.4

7.1

3.4

4.1

0.8

 < 0.001*

26.1%

3.6

0.86

 < 0.001*

19.6%

  Final Score

14.6

4.2

9.2

4.4

5.4

1.0

 < 0.001*

27.7%

4.9

1.10

 < 0.001*

21.7%

Case 5: Smoker with cardiovascular diseases

  Total Analytical Score (# of items:27)

12.6

3.9

5.7

2.7

7.0

0.8

 < 0.001*

48.6%

6.9

0.83

 < 0.001*

53.1%

  Final Score

16.3

4.7

8.3

3.6

8.0

1.0

 < 0.001*

45.4%

8.2

1.05

 < 0.001*

50.1%

Case 6: Smoker in precontemplation stage of change

  Total Analytical Score (# of items:23)

11.7

3.6

8.1

4.0

3.6

0.9

 < 0.001*

18.5%

4.3

0.90

 < 0.001*

28.4%

  Final Score

15.2

4.2

11.3

4.9

3.9

1.0

 < 0.001*

15.7%

4.5

1.05

 < 0.001*

28.8%

  1. aAdjusted for age, gender, years of practicing as pharmacist in Qatar, smoking status and previous training in relation to tobacco use and treatment * statistically significant